{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:26:23Z","timestamp":1774581983021,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","publichealthjrnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.puhe.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T13:24:05Z","timestamp":1458221045000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A comparison of secondary prevention practice in\u00a0poststroke and coronary heart disease patients"],"prefix":"10.1016","volume":"137","author":[{"given":"J.","family":"Van\u011bk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-3749","authenticated-orcid":false,"suffix":"Jr.","given":"O.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seidlerov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bruthans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kielbergerov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kraj\u010doviechov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Filipovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"C\u00edfkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2016.02.003_bib1","first-page":"1300","article-title":"Prevention of coronary heart disease in clinical practice. Recommendation of the task force of the European society of cardiology, European atherosclerosis society and European society of hypertension","volume":"15","author":"Py\u00f6r\u00e4l\u00e4","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention on clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice","volume":"24","author":"De Backer","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","volume":"14","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.puhe.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/oxfordjournals.eurheartj.a015136","article-title":"EUROASPIRE. A European society of cardiology survey of secondary prevention of coronary heart disease: principal results","volume":"18","author":"EUROASPIRE Study Group","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/euhj.2001.2610","article-title":"Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II","volume":"22","author":"EUROASPIRE II Group","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.puhe.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","article-title":"EUROASPIRE study group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries","volume":"16","author":"Kotseva","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.puhe.2016.02.003_bib9","article-title":"The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic","volume":"56","author":"Mayer","year":"2014","journal-title":"A Comp EUROASPIRE I, II, III IV Study Cor Vasa"},{"key":"10.1016\/j.puhe.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/2047487314546825","article-title":"Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey","volume":"22","author":"Heuschmann","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.puhe.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.33678\/cor.2008.167","article-title":"The standards of secondary of stroke in Czech patients in the EUROASPIRE III study\/stroke specific module","volume":"50","author":"Bruthans","year":"2008","journal-title":"Cor Vasa"},{"key":"10.1016\/j.puhe.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/HJH.0000000000000414","article-title":"Low blood pressure during the acute period of ischemic stroke is associated with decreased survival","volume":"33","author":"Wohlfahrt","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.puhe.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.puhe.2016.02.003_bib14","first-page":"710","article-title":"Poststroke antihypertensive treatment study: a preliminary result","volume":"108","author":"PATS Collaborating Group","year":"1995","journal-title":"Chin Med J Engl"},{"key":"10.1016\/j.puhe.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"Stroke prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.puhe.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.puhe.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archinte.160.7.939","article-title":"Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies","volume":"160","author":"Wilson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.puhe.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative metaanalysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a metaanalysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1212\/WNL.0b013e31822f0423","article-title":"AVAIL investigators. Secondary preventive medication persistence and adherence 1 year after stroke","volume":"77","author":"Bushnell","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.puhe.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000097646","article-title":"Helsingborg declaration 2006 on European stroke strategies","volume":"23","author":"Kjellstr\u00f6m","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.puhe.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.puhe.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/CIRCOUTCOMES.109.921858","article-title":"GWTG-stroke steering committee and investigators characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke","volume":"3","author":"Fonarow","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350616000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350616000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T13:07:58Z","timestamp":1567688878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350616000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":24,"alternative-id":["S0033350616000603"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2016.02.003","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of secondary prevention practice in\u00a0poststroke and coronary heart disease patients","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}